ReviewBritish journal of pharmacology2004

Neurokinin NK1 and NK3 receptors as targets for drugs to treat gastrointestinal motility disorders and pain.

Gareth J SangerPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.